Actionable disease insights from bedside-to-bench investigation in fibrodysplasia ossificans progressiva

J Bone Miner Res. 2024 May 2;39(4):375-376. doi: 10.1093/jbmr/zjae044.

Authors

Marc N Wein¹, Yingzi Yang²

Affiliations

¹ Endocrine Unit, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, United States.
² Department of Developmental Biology, Harvard School of Dental Medicine, Boston, MA 02115, United States.

PMID: 38644656
DOI: 10.1093/jbmr/zjae044

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Humans
Myositis Ossificans* / diagnosis
Myositis Ossificans* / genetics
Myositis Ossificans* / metabolism
Translational Research, Biomedical